BioCentury
ARTICLE | Company News

Teva sales and marketing update

September 14, 2015 7:00 AM UTC

Teva launched Zecuity sumatriptan in the U.S. for the acute treatment of migraine with or without aura. The wholesale acquisition cost (WAC) for the transdermal patch delivering sumatriptan via ionto...